Sionna Therapeutics to Attend RBC Healthcare Conference

Sionna Therapeutics, a clinical-stage biopharmaceutical company, has announced its participation in the upcoming 2026 RBC Capital Markets Global Healthcare Conference. This event provides a significant platform for the company to engage with investors and industry leaders, discussing its progress and future prospects. As a company focused on developing innovative treatments, Sionna Therapeutics will likely highlight its pipeline and strategic objectives during the conference. The participation underscores the company's commitment to advancing its mission within the healthcare sector and seeking potential collaborations or funding opportunities.